Apoptosis Antibodies
Apoptosis refers to the set of ordered biochemical and physical changes in a cell during a specific form of cell death. These changes begin with the rounding and shrinking of the affected cells causing them to lose contact with their neighbors. Later, their endoplasmic reticulum swells and the cisternae begin to form vesicles and vacuoles. In the nucleus, the chromatin condenses and is digested by endogenous nucleases. The nucleus ultimately disintegrates into fragments which are encapsulated into apoptotic bodies. By this point, the plasma membrane has become convoluted and begins blebbing off, forming the surface of the apoptotic bodies, which are then recognized and engulfed by phagocytic cells. In contrast, during necrosis the cell swells and disintegrates in a disordered manner, leading to the destruction of cellular organelles and the rupture of the plasma membrane.
ProSci has a wide variety of apoptosis antibodies. These include antibodies against p53 upregulated modulator of apoptosis (PUMA), Bim, members of the caspase family, death receptors, p53 and many other apoptosis proteins. Additionally, ProSci offers a BAFF and Receptor Detection Set and a TRAIL and Receptor Detection set. ProSci antibodies are appropriate for ELISA, western blot, and immunohistochemistry (IHC) applications as noted for each apoptosis antibody.
Also, we have a TRAIL and TRAIL receptor flyer in the posters section of our resources area of the ProSci website and our TRAIL and TRAIL receptor products were featured in our May 2006 newsletter which is also in the posters section of our resources area.
Apoptosis Antibodies from ProSci:
| Product Name | Catalog # | App. | Reactivity | Description |
|---|---|---|---|---|
| ICAD Antibody | 2003 | E, WB | M | (CT) Inhibitor of CAD |
| ICAD Antibody | 2001 | E, WB, IHC, IF | M | (NT) Inhibitor of CAD |
| IEX-1 Antibody | 4247 | E, WB, IHC, IF | H, M | (IN) a stress inducible gene that is induced by io |
| IGF-BP5 Antibody | 38-289 | E, WB, IHC | H | Anti-Human IGF-BP5 |
| IkB-a Antibody | 79-175 | WB, IHC, IF | H, M, R | IkB-a (Phospho-Ser32/Ser36) |
| IkB-a Antibody | 79-327 | WB, IHC, IF | H, M, R | IkB-a (Ab-32/36) |
| IkB-a Antibody | 79-350 | WB, IHC | H, M, R | IkB-a (Ab-42) |
| IkB-a Antibody | 79-180 | WB, IHC | H, M, R | IkB-a (Phospho-Tyr42) |
| IkB-beta Antibody | 79-232 | IHC | H, M, R | IkB-beta (Phospho-Ser23) |
| IkB-epsilon Antibody | 79-197 | WB, IHC | H, M | IkB-epsilon (Phospho-Ser22) |
| IkB-epsilon Antibody | 79-404 | WB, IHC | H, M | IkB-epsilon (Ab-22) |
| IKBKB Antibody | 49-609 | WB, IHC | M, R | IKB Kinase Beta |
| IKBKB Antibody | 49-587 | E, WB, IHC, IF, IP | H | IKB Kinase Beta |
| IKBKG Antibody | 27-263 | E, WB | H, D | IKBKG (inhibitor of kappa light polypeptide gene e |
| IKK a Antibody | 79-161 | WB, IHC | H, M, R | IKK a (Phospho-Thr23) |
| IKK a Antibody | 79-328 | WB, IHC | H, M, R | IKK a (Ab-23) |
| ILP-2 Antibody | 3017 | E, WB, ICC, IF | H, M, R | (NT) A novel member in IAP family |
| ILPIP Antibody | 3199 | E, WB, IHC | H, M, R | (IN) An IAP binding protein |
| ILPIP Antibody | 3201 | E, WB, IHC | H | (CT) An IAP binding protein |
| INCA Antibody | 42-270 | E, WB | H | (CT) INCA |
| ING1 Antibody | 30-622 | E, WB | H, M, R | ING1 (inhibitor of growth family, member 1) |
| INHA Antibody | 26-810 | E, WB | H | INHA (inhibin, alpha) |
| Inhibitor of Apoptosis Protein Detection Set | PSI-1815 | WB, IHC | see datasheet | cIAP, ILP-2, Livin, NAIP, Survivin, XIAP |
| Ipaf Antibody | 3107 | E, WB, ICC, IF | H | (CT) ICE protease activating factor |
| IRF1 Antibody | 28-794 | E, WB | H, M, R, D | IRF1 (interferon regulatory factor 1) |
| IRF5 Antibody | 45-075 | E, WB, IP, ChIP | H | (CT) IRF5 |
| ITGB3BP Antibody | 26-958 | E, WB | H | ITGB3BP (integrin beta 3 binding protein (beta3-en |
| ITM2B Antibody | XW-7314 | WB | H | Integral membrane protein 2B |

